||
文献检索分析结果
http://www.pubmedplus.cn/P/SearchQuickResult?wd=65e54707-4567-4bf1-9e71-8ec74515004f
01. | 2021 | 1 篇 | 4.348% |
02. | 2020 | 3 篇 | 13.043% |
03. | 2019 | 8 篇 | 34.783% |
04. | 2018 | 4 篇 | 17.391% |
05. | 2016 | 4 篇 | 17.391% |
06. | 2015 | 2 篇 | 8.696% |
07. | 2014 | 1 篇 | 4.348% |
01. | world j gastroenterol | 2 篇 | 8.696% |
02. | biochim biophys acta rev cancer | 1 篇 | 4.348% |
03. | biomed pharmacother | 1 篇 | 4.348% |
04. | cancer sci | 1 篇 | 4.348% |
05. | clin j gastroenterol | 1 篇 | 4.348% |
06. | cold spring harb perspect med | 1 篇 | 4.348% |
07. | curr treat options oncol | 1 篇 | 4.348% |
08. | expert opin investig drugs | 1 篇 | 4.348% |
09. | expert opin pharmacother | 1 篇 | 4.348% |
10. | expert rev anticancer ther | 1 篇 | 4.348% |
01. | 中国 | 10 篇 | 43.478% |
02. | 美国 | 4 篇 | 17.391% |
03. | 日本 | 4 篇 | 17.391% |
04. | 印度 | 2 篇 | 8.696% |
05. | 澳大利亚 | 1 篇 | 4.348% |
06. | 巴西 | 1 篇 | 4.348% |
07. | 德国 | 1 篇 | 4.348% |
08. | 土耳其 | 1 篇 | 4.348% |
01. | 中国上海 | 3 篇 | 13.043% |
02. | 中国北京 | 1 篇 | 4.348% |
03. | 中国南京 | 1 篇 | 4.348% |
04. | 中国淮安 | 1 篇 | 4.348% |
05. | 中国杭州 | 1 篇 | 4.348% |
06. | 中国济南 | 1 篇 | 4.348% |
07. | 中国武汉 | 1 篇 | 4.348% |
08. | 中国兰州市 | 1 篇 | 4.348% |
01. | Antineoplastic Agents | 23 篇 | 100.000% |
02. | Carcinoma, Hepatocellular | 23 篇 | 100.000% |
03. | Humans | 23 篇 | 100.000% |
04. | Immunotherapy | 23 篇 | 100.000% |
05. | Liver Neoplasms | 23 篇 | 100.000% |
06. | Molecular Targeted Therapy | 23 篇 | 100.000% |
07. | Animals | 8 篇 | 34.783% |
08. | Treatment Outcome | 6 篇 | 26.087% |
09. | Chemoembolization, Therapeutic | 4 篇 | 17.391% |
10. | Clinical Trials as Topic | 4 篇 | 17.391% |
相关研究文献
2. 溴和末端外结构域蛋白抑制可提高肝细胞癌的免疫治疗效果。
Department of Surgery, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, China.
Cancer Sci (P 1349-7006 E 1347-9032) H指数:129 2020 年 111 卷 10 期 3503-3515 页
PMID:32726482 相似文献
英
汉
3. 用舒尼替尼苹果酸调节肿瘤免疫微环境支持免疫治疗联合治疗的基本原理。
Wei Li,Meixiao Zhan,Ying-Yao Quan,Hao Wang,Sheng-Ni Hua,Yong Li,Jianjun Zhang,Ligong Lu,Min Cui
Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China; Department of General Surgery, Zhuhai People's Hospital, Jinan University, Zhuhai, Guangdong, People's Republic of China.
zhangjianjun0221@126.com
Int Immunopharmacol (P 1878-1705 E 1567-5769) H指数:98 2020 年 81 卷 106227 页
PMID:32078941 相似文献
英
汉
David Anwanwan,Santosh Kumar Singh,Shriti Singh,Varma Saikam,Rajesh Singh
Department of Microbiology, Biochemistry and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA.
rsingh@msm.edu
Biochim Biophys Acta Rev Cancer (P 1879-2561 E 0304-419X) H指数:0 2020 年 1873 卷 1 期 188314 页
PMID:31682895 相似文献
英
汉
Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, The James Comprehensive Cancer Center, Columbus, Ohio, USA.
Expert Opin Investig Drugs (P 1744-7658 E 1354-3784) H指数:94 2019 年 28 卷 11 期 941-949 页
PMID:31590579 相似文献
英
汉
Mengxin Tian,Yinghong Shi,Weiren Liu,Jia Fan
Department of Liver Surgery & Transplantation Center, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
fan.jia@zs-hospital.sh.cn
Sci China Life Sci (P 1869-1889 E 1674-7305) H指数:43 2019 年 62 卷 9 期 1138-1143 页
PMID:31119560 相似文献
英
汉
Jens U Marquardt,Anna Saborowski,Carolin Czauderna,Arndt Vogel
Department of Medicine, Lichtenberg Research Group for Molecular Hepatocarcinogenesis, University of Mainz, Mainz, Germany.
vogel.arndt@mh-hannover.de
Target Oncol (P 1776-260X E 1776-2596) H指数:35 2019 年 14 卷 2 期 115-123 页
PMID:30805831 相似文献
英
汉
Rachael Chang Lee,Niall Tebbutt
a Department of Medical Oncology , Olivia Newton-John Cancer Wellness and Research Centre , Heidelberg , Australia.
Expert Rev Anticancer Ther (P 1744-8328 E 1473-7140) H指数:59 2019 年 19 卷 4 期 343-353 页
PMID:30793991 相似文献
英
汉
10. 用于治疗晚期肝癌:最近的进步,目前的困境,以及未来的发展方向。
Jing Zhu,Tailang Yin,Yong Xu,Xiao-Jie Lu
Department of General Surgery, Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, The Sparkfire Scientific Research Group of Nanjing Medical University, Nanjing, China.
J Cell Physiol (P 1097-4652 E 0021-9541) H指数:158 2019 年 234 卷 8 期 12122-12132 页
PMID:30644100 相似文献
英
汉
Kabir Mody,Ghassan K Abou-Alfa
Mayo Clinic Cancer Center, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. mody.kabir@mayo.edu.
mody.kabir@mayo.edu
Curr Treat Options Oncol (P 1534-6277 E 1534-6277) H指数:48 2019 年 20 卷 2 期 3 页
PMID:30635732 相似文献
英
汉
13. 有针对性的和基于免疫疗法为肝癌。
Tim F Greten,Chunwei Walter Lai,Guangfu Li,Kevin F Staveley-O'Carroll
Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; National Cancer Institute CCR Liver Cancer Program, Bethesda, Maryland. Electronic address: tim.greten@nih.gov.
tim.greten@nih.gov
Gastroenterology (P 1528-0012 E 0016-5085) H指数:368 2019 年 156 卷 2 期 510-524 页
PMID:30287171 相似文献
文摘 DOI链接 Elsevier ScienceClinicalKeyEurope PubMed CentralPubMed Central
英
汉
14. 口服化疗药物对肝癌的治疗。
a Hepatobiliary and Pancreatic Oncology Division , National Cancer Center Hospital , Tokyo , Japan.
Expert Opin Pharmacother (P 1744-7666 E 1465-6566) H指数:69 2018 年 19 卷 9 期 993-1001 页
PMID:29913090 相似文献
英
汉
15. 肝癌:有针对性和免疫疗法的审查。
Daniel da Motta Girardi,Tatiana Strava Correa,Marcela Crosara Teixeira,Gustavo Dos Santos Fernandes
Division of Medical Oncology, Hospital Sírio-Libanês, SGAS 613 conj E Bl B, Brasilia, DF, 70200730, Brazil. danielmgirardi@gmail.com.
danielmgirardi@gmail.com
J Gastrointest Cancer (P 1941-6636 E ) H指数:44 2018 年 49 卷 3 期 227-236 页
PMID:29806062 相似文献
英
汉
16. 化疗对肝癌:现状和未来前景。
Masafumi Ikeda,Chigusa Morizane,Makoto Ueno,Takuji Okusaka,Hiroshi Ishii,Junji Furuse
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa.
Jpn J Clin Oncol (P 1465-3621 E 0368-2811) H指数:79 2018 年 48 卷 2 期 103-114 页
PMID:29253194 相似文献
英
汉
17. “肝细胞癌:威胁生命的疾病”。
Division of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835215, India. Electronic address: shinu10015@bitmesra.ac.in.
shinu10015@bitmesra.ac.in
Biomed Pharmacother (P 1950-6007 E 0753-3322) H指数:78 2016 年 84 卷 1679-1688 页
PMID:27823920 相似文献
英
汉
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Oncotarget (P 1949-2553 E 1949-2553) H指数:91 2016 年 7 卷 43 期 71036-71051 页
PMID:27626176 相似文献
文摘 DOI链接 Impact Journals, LLCEurope PubMed CentralPubMed Central
英
汉
19. 化疗的晚期肝癌的现状和未来前景。
Michihisa Moriguchi,Atsushi Umemura,Yoshito Itoh
Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokouji, Kamigyo-ku, Kyoto, 602-8566, Japan. mmori@koto.kpu-m.ac.jp.
mmori@koto.kpu-m.ac.jp
Clin J Gastroenterol (P 1865-7265 E 1865-7265) H指数:11 2016 年 9 卷 4 期 184-90 页
PMID:27401471 相似文献
英
汉
20. 肝细胞癌手术与非手术治疗的进展。
Ender Gunes Yegin,Erkan Oymaci,Emrah Karatay,Ahmet Coker
Department of Gastroenterology, Bozyaka Training and Research Hospital, Izmir 35170, Turkey. drendergunes@hotmail.com.
drendergunes@hotmail.com
Hepatobiliary Pancreat Dis Int (P 1499-3872 E ) H指数:40 2016 年 15 卷 3 期 234-56 页
PMID:27298100 相似文献
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-10-20 04:54
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社